Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $20.32 is 41.11% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 20.98||$ 22.74|
|Low:||$ 20.22||$ 14.40|
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API, products. We currently manufacture and sell over 20 products. Additionally, we are currently developing a portfolio of 15 generic abbreviated new drug applications, or ANDAs, three generic biosimilar product candidates and six proprietary product candidates. For the years ended December 31, 2017, 2016, and 2015, we recorded net revenues of $240.2 million, $255.2 million, and $251.5 million, respectively. We recorded net income of $4.5 million and $10.5 million for the years ended December 31, 2017 and 2016, respectively, and recorded a net loss of $2.8 million for the year ended December 31, 2015. ... More ...
Nasdaq Official Price
Dec. 14, 2018
Dec. 14, 2018